NCT03972488 2026-01-21NETTER-2Advanced Accelerator ApplicationsPhase 3 Active not recruiting226 enrolled 14 charts
NCT02779257 2022-03-04Pasireotide Treatment for Neuroendocrine TumorUniversity of Maryland, BaltimorePhase 4 Withdrawn